Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
The University of North Carolina at Wilmington currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is overseen by 1 distinct examiner, GENBIN SHI, in 1 distinct art unit. GENBIN SHI is the busiest examiner, holding 1 busiest examiner pending action. With 1 pending office action, the university's current prosecution efforts are limited to this single examiner and art unit.
The 1 distinct examiner and 1 distinct art unit assigned to this Biotechnology & Pharmaceuticals matter represent the full scope of the university's current pending workload. GENBIN SHI, as the busiest examiner, is responsible for the 1 busiest examiner pending action, meaning there are no other examiners to consider in the current strategy. This singular focus allows for a direct and streamlined communication channel with the patent office. Practitioners should note that the success of the current portfolio depends entirely on the 1 pending office action being handled by this specific examiner within their assigned art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHI, GENBIN | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18516608 | PREPARATION AND ACTIVITY CHARACTERIZATION OF CANNABICITRAN ENANTIOMERS | SHI, GENBIN | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18516608 | PREPARATION AND ACTIVITY CHARACTERIZATION OF CANNABICITRAN ENANTIOMERS | SHI, GENBIN | 1628 | §103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial